BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21926424)

  • 1. Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase.
    Butler RK; Ford GK; Hogan M; Roche M; Doyle KM; Kelly JP; Kendall DA; Chapman V; Finn DP
    J Psychopharmacol; 2012 Jan; 26(1):83-91. PubMed ID: 21926424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
    Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
    Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
    Olango WM; Roche M; Ford GK; Harhen B; Finn DP
    Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats.
    Ford GK; Kieran S; Dolan K; Harhen B; Finn DP
    Pain; 2011 Nov; 152(11):2495-2504. PubMed ID: 21864979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner.
    Rea K; McGowan F; Corcoran L; Roche M; Finn DP
    Br J Pharmacol; 2019 May; 176(10):1492-1505. PubMed ID: 29847859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
    Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
    Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually Dimorphic Expression of Fear-conditioned Analgesia in Rats and Associated Alterations in the Endocannabinoid System in the Periaqueductal Grey.
    Llorente-Berzal A; McGowan F; Gaspar JC; Rea K; Roche M; Finn DP
    Neuroscience; 2022 Jan; 480():117-130. PubMed ID: 34774710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats.
    Rea K; Olango WM; Harhen B; Kerr DM; Galligan R; Fitzgerald S; Moore M; Roche M; Finn DP
    Pain; 2013 Apr; 154(4):576-585. PubMed ID: 23414578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear.
    Roche M; Johnston P; Mhuircheartaigh ON; Olango WM; Mackie K; Finn DP
    Eur J Pain; 2010 May; 14(5):487-95. PubMed ID: 19786358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats.
    Roche M; O'Connor E; Diskin C; Finn DP
    Eur J Neurosci; 2007 Nov; 26(9):2643-53. PubMed ID: 17970731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
    Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
    Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel molecular correlates of endocannabinoid-mediated fear-conditioned analgesia in rats.
    Olango WM; Géranton SM; Roche M; Hunt SP; Finn DP
    Eur J Pain; 2014 Feb; 18(2):182-91. PubMed ID: 23873727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.